Daegu, South Korea

Hyang-Sook Hoe

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 21.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyang-Sook Hoe: Innovator in Pharmaceutical Composition

Introduction

Hyang-Sook Hoe is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of protein kinase-related diseases.

Latest Patents

Hyang-Sook Hoe holds a patent for a pyrrolo-pyridine derivative compound, which includes a method for preparing the compound and a pharmaceutical composition that utilizes it as an active ingredient. This invention is particularly relevant for the prevention or treatment of diseases related to protein kinases, such as Alzheimer's disease and dementia. The compound demonstrates excellent inhibitory activity against various protein kinases, including DYRK1A, making it a promising candidate for therapeutic applications.

Career Highlights

Throughout his career, Hyang-Sook Hoe has been associated with reputable organizations such as the Daegu-Gyeongbuk Medical Innovation Foundation and the Korea Research Institute of Bioscience and Biotechnology. His work has focused on innovative solutions in the medical field, contributing to advancements in treatment methodologies.

Collaborations

Hyang-Sook Hoe has collaborated with professionals like Hwan Geun Choi and Eunhwa Ko, enhancing the scope and impact of his research and inventions.

Conclusion

Hyang-Sook Hoe's contributions to pharmaceutical innovation, particularly through his patented compound, highlight his role as a key figure in the fight against protein kinase-related diseases. His work continues to pave the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…